Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants.

@article{Stahl2008MonoamineOI,
  title={Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants.},
  author={S. Stahl and A. Felker},
  journal={CNS spectrums},
  year={2008},
  volume={13 10},
  pages={
          855-70
        }
}
  • S. Stahl, A. Felker
  • Published 2008
  • Medicine, Psychology
  • CNS spectrums
  • Monoamine oxidase inhibitors (MAOIs) currently have a "bad rap" and are thus infrequently used in psychopharmacology, even by experienced clinicians. Misinformation about the dietary and drug interactions of MAOIs is widespread, whereas pragmatic tips for utilizing MAOIs to minimize risks and to maximize therapeutic actions are largely lacking in the contemporary literature. While clearly not first-line treatments, MAOIs, in the hands of experienced and well-informed clinicians, can be a… CONTINUE READING
    Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression
    106
    Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant Treatment
    Critical appraisal of selegiline transdermal system for major depressive disorder
    5
    Drugs related to monoamine oxidase activity
    35

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 80 REFERENCES
    A clinical overview of monoamine oxidase inhibitors.
    38
    Revisiting monoamine oxidase inhibitors.
    62